Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420

Watchlist Manager
Shanghai Shyndec Pharmaceutical Co Ltd Logo
Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420
Watchlist
Price: 12.1 CNY -4.72% Market Closed
Market Cap: 16.2B CNY
Have any thoughts about
Shanghai Shyndec Pharmaceutical Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

6.9
Current
9.1
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
6.9
=
Enterprise Value
10.1B CNY
/
EBIT
1.5B CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
N/A
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A

See Also

Discover More